Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ASF | Ann: ASF NTA 02-09-2025 $12.26194 | 08:00 | 0 | 18 | |||
|
|||||||
ASF | Ann: ASF NTA 01-09-2025 $12.19415 | 02/09/25 | 0 | 33 | |||
|
|||||||
ASF | Ann: ASF NTA 29-08-2025 $12.29486 | 01/09/25 | 0 | 27 | |||
|
|||||||
ASF | Ann: ASF NTA 28-08-2025 $12.37523 | 29/08/25 | 0 | 34 | |||
|
|||||||
ASF | Ann: ASF NTA 27-08-2025 $12.32602 | 28/08/25 | 0 | 34 | |||
|
|||||||
ASF | Ann: ASF NTA 26-08-2025 $12.24017 | 27/08/25 | 0 | 45 | |||
|
|||||||
ASF | Ann: ASF NTA 25-08-2025 $12.28861 | 26/08/25 | 0 | 65 | |||
|
|||||||
ASF | Ann: ASF NTA 22-08-2025 $12.40693 | 25/08/25 | 0 | 45 | |||
|
See All Discussions